Form 8-K - Current report:
SEC Accession No. 0001104659-25-029887
Filing Date
2025-03-31
Accepted
2025-03-31 16:18:43
Documents
13
Period of Report
2025-03-25
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510844d2_8k.htm   iXBRL 8-K 30610
  Complete submission text file 0001104659-25-029887.txt   203907

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctso-20250325.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20250325_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20250325_pre.xml EX-101.PRE 22367
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2510844d2_8k_htm.xml XML 3565
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 25793539
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)